The natural history of Noonan syndrome: A long-term follow-up study

Archives of Disease in Childhood

Volumn 92, Issue 2, 2007, Pages 128-132

  Shaw, A C ^a   Kalidas, K ^a   Crosby, A H ^a   Jeffery, S ^a   Patton, M A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE; GENE MUTATION; HEART FAILURE; HISTORY OF MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NOONAN SYNDROME; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PTPN11 GENE; PULMONARY VALVE STENOSIS; SCHOOL CHILD; TRANSLUMINAL VALVULOPLASTY;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; AGED; BODY HEIGHT; CAUSE OF DEATH; CHILD; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; GROWTH; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT NUTRITION PHYSIOLOGY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; NOONAN SYNDROME; PHENOTYPE; PROGNOSIS; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 33847075012     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.104547     Document Type: Article

References (27)

1. Sharland M, Burch M, McKenna WM, et al. A clinical study of Noonan syndrome. Arch Dis Child 1992;67:178-83.
2. Allanson JE. Noonan syndrome. J Med Genet 1987;24:9-13.
3. Jamieson CR, van der Burgt I, Brady AF, et al. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet 1994;8:357-60.
4. Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001;29:465-8.
5. Neel BG, Gu H, Pao L. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 2003;28:284-93.
6. Tartaglia M, Kalidas K, Shaw A, et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 2002;70:1555-63.
7. Zenker M, Buheitel G, Rauch R, et al. Genotype-phenotype correlations in Noonan syndrome. J Pediatr 2004;144:368-74.
8. Musante L, Kehl HG, Majewski F, et al. Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. Eur J Hum Genet 2003;11:201-6.
9. Sarkozy A, Conti E, Seripa D, et al. Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J Med Genet 2003;40:704-8.
10. Mendez HM, Opitz JM. Noonan syndrome: a review. Am J Med Genet 1985;21:493-506.
11. Allanson JE, Hall JG, Hughes HE, et al. Noonan syndrome: the changing phenotype. Am J Med Genet 1985;21:507-14.
12. Noonan JA, Raaijmakers R, Hall BD. Adult height in Noonan syndrome. Am J Med Genet A 2003;123:68-71.
13. van der Burgt I, Berends E, Lommen E, et al. Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet 1994;53:187-91.
14. Hammond P, Hutton TJ, Allanson JE, et al. 3D analysis of facial morphology. Am J Med Genet A 2004;126:339-48.
15. Cohen MM Jr, Gorlin RJ. Noonan-like/multiple giant cell lesion syndrome. Am J Med Genet 1991;40:159-66.
16. Witt DR, Keena BA, Hall JG, et al. Growth curves for height in Noonan syndrome. Clin Genet 1986;30:150-3.
17. Ranke MB, Heidemann P, Knupfer C, et al. Noonan syndrome: growth and clinical manifestations in 144 cases. Eur J Pediatr 1988;148:220-7.
18. Ferreira LV, Souza SA, Arnhold IJ, et al. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome. J Clin Endocrinol Metab 2005;90:5156-60.
19. Limal JM, Parfait B, Cabrol S, et al. Noonan syndrome: relationships between genotype, growth, and growth factors. J Clin Endocrinol Metab 2006;91:300-6.
20. Masura J, Burch M, Deanfield JE, et al. Five-year follow-up after balloon pulmonary valvuloplasty. J Am Coll Cardiol 1993;21:132-6.
21. McCrindle BW. Independent predictors of long-term results after balloon pulmonary valvuloplasty. Valvuloplasly and Angioplasty of Congenital Anomalies (VACA) Registry Investigators. Circulation 1994;89:1751- 9.
22. Burch M, Mann JM, Sharland M, et al. Myocardial disarray in Noonan syndrome. Br Heart J 1992;68:586-8.
23. Reilly S, Skuse D, Poblete X. Prevalence of feeding problems and oral motor dysfunction in children with cerebral palsy: a community survey. J Pediatr 1996;129:877-82.
24. Stallings VA, Charney EB, Davies JC, et al. Nutrition-related growth failure of children with quadriplegic cerebral palsy. Dev Med Child Neurol 1993;35:126-38.
25. Shah N, Rodriguez M, Louis DS, et al. Feeding difficulties and foregut dysmotility in Noonan syndrome. Arch Dis Child 1999;81:28-31.
26. Sharland M, Patton MA, Talbot S, et al. Coagulation-factor deficiencies and abnormal bleeding in Noonan syndrome. Lancet 1992;339:19-21.
27. Tartaglia M, Niemeyer CM, Fragale A, et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003;34:148-50.